Tumor response to neoadjuvant chemotherapy in molecular breast cancer subtypes in Medellin, Colombia. Retrospective cohort study
Manuela Restrepo-MejíaAna Maria Guarín-GarcíaÓscar Alejandro Bonilla-SepúlvedaMelissa Rincón-MedinaLina Marcela Barrera-ArenasPublished in: Revista colombiana de obstetricia y ginecologia (2023)
In clinical practice, breast cancer classification by molecular subtypes is a means to approach the assess the to neoadjuvant chemotherapy. Prospective studies are needed in the region in order to determine the ability to predict overall and disease-free survival based on the complete pathologic response.